Clinical Trials

Currently Accepting

Characteristics of Patients with Recessive Dystrophic Epidermolysis Bullosa >

Long Term Open-Label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex >

Safety, Pharmakinetics and Efficacy of Dupilumab in Patients ≥ 6 Months to < 6 Years with Severe Atopic Dermatitis (Liberty AD Preschool) >

Study of Diacerein After Maximum Use in Patients with EB >

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants >

Sildenafil for the Treatment of Lymphatic Malformations >

Topical Remetinostat Gel as Neoadjuvant Therapy in Patients with Squamus Cell Carcinoma (SCC) >

Topical Remetinostat in Treating Patient with Cutaneous Basal Cell Cancer >

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbiome Interface in Atopic Dermatitis >

A Study of Baricitinib (LY3009104) in Participants with Severe or Very Severe Alopecia Areata >

SAR231893-LPS15497 - “Dupilumab Effect on Sleep in AD Patients” >

A Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis >

A Study to Evaluate Upadacitinib in Combination with Topical Corticosteroids in Adolescent and Adult Participants with Moderate to Severe Atopic Dermatitis >

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults with Alopecia Areata >

A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients with Epidermolysis Bullosa >

Evaluation of Upadacitinib in Adolescent and Adult Patients with Moderate to Severe Atopic Dermatitis (Eczema) - Measure Up 1 >

Topical Bercolagene Telserpavec (KB103) Gene Therapy to Restore Functional Collagen VII for the Treatment of Dystrophic Epidermolysis Bullosa >

Topical QR-313 in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Due to Mutation(s) in Exon 73 of the COL7A1gene >

A Phase 1/2 Trial of PTR-01 in Adult Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) >